Full Press Release Details
WATERTOWN, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage biotechnology company developing novel, integrated drug and delivery solutions for the localized treatment of patients with chronic rhinosinusitis (CRS), today announced that Maria Palasis, Ph.D., President and Chief Executive Officer, will present at the following investor conferences in November:
Stifel 2022 Healthcare Conference – Presentation on Tuesday, November 15, 2022 at 4:10 p.m. ET
Jefferies London Healthcare Conference – Fireside chat on Thursday, November 17, 2022 at 4:25 p.m. GMT (11:25 a.m. ET)
Webcasts of the presentation and fireside chat may be accessed on the Investor Relations section of the Company's website at investors.lyratherapeutics.com. Replays of the webcasts will be available for 90 days following the events.
About Lyra Therapeutics